Cargando…

Real‐world risk of lower‐limb amputation associated with sodium–glucose cotransporter 2 inhibitors versus metformin: A propensity score‐matched model analysis in Japan

AIMS/INTRODUCTION: We aimed to clarify the real‐world risk of lower‐limb amputation and identify factors related to increased risk in Japanese patients with type 2 diabetes using sodium–glucose cotransporter 2 inhibitors (SGLT2is). MATERIALS AND METHODS: We carried out a retrospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizutani, Gen, Horii, Takeshi, Oikawa, Yoichi, Atsuda, Koichiro, Shimada, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720178/ https://www.ncbi.nlm.nih.gov/pubmed/36124433 http://dx.doi.org/10.1111/jdi.13906

Ejemplares similares

On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes
por: Horii, Takeshi, et al.
Publicado: (2021)

Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan
por: Horii, Takeshi, et al.
Publicado: (2023)

Acute kidney injury in Japanese type 2 diabetes patients receiving sodium–glucose cotransporter 2 inhibitors: A nationwide cohort study
por: Horii, Takeshi, et al.
Publicado: (2021)

Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
por: Horii, Takeshi, et al.
Publicado: (2020)

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase‐4 inhibitors in treatment‐naïve patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020)

Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis
por: Wang, Jinkui, et al.
Publicado: (2022)

Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
por: Yamashita, Yasunari, et al.
Publicado: (2021)

Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models
por: Kobayashi, Kazuo, et al.
Publicado: (2020)

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

Cancer-Specific Survival after Limb Salvage versus Amputation in Children and Adolescents with Osteosarcoma: A Population-Based Analysis with Propensity Score Matching
por: Li, Zhenwei, et al.
Publicado: (2023)

Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan
por: Sen, Rohini, et al.
Publicado: (2016)

Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
por: Mui, Jonathan V., et al.
Publicado: (2023)

In-Utero Limb Amputation
por: Sharma, Vibha, et al.
Publicado: (2017)

Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis
por: Toyoda, Masao, et al.
Publicado: (2022)

Impact of early initiation of sodium-glucose cotransporter 2 inhibitor on cardiovascular outcomes in people with diabetes and known or at risk of atherosclerotic cardiovascular disease: Propensity score matched analysis
por: Sun, Wen, et al.
Publicado: (2022)

Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis
por: Heyward, James, et al.
Publicado: (2020)

Iodide Binding in Sodium-Coupled Cotransporters
por: Vergara-Jaque, Ariela, et al.
Publicado: (2017)

Complete Amputation of Two Limbs
Publicado: (1902)

Pattern of Limb Amputations in Liberia
por: Weyhee, Joseph K., et al.
Publicado: (2019)

Risk Factors for Non-Adherence to Medications That Affect Surgery: A Retrospective Study in Japan
por: Akamine, Akihiko, et al.
Publicado: (2022)

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Jeon, Ja Young, et al.
Publicado: (2021)

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity
por: Wan, Ningning, et al.
Publicado: (2018)

Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review
por: Matsumura, Koichiro, et al.
Publicado: (2019)

Expression of the sodium potassium chloride cotransporter (NKCC1) and sodium chloride cotransporter (NCC) and their effects on rat lens transparency
por: Chee, K.N., et al.
Publicado: (2010)

Venous thromboembolism risk factors and usefulness of a risk scoring system in lower limb orthopedic surgery: A case-control study in Japan
por: Akamine, Akihiko, et al.
Publicado: (2022)

Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2012)

Type 2 Diabetes Remission and Substantial Body Weight Reduction Achieved with Metformin and a Sodium-Glucose Cotransporter 2 Inhibitor
por: Sugiyama, Seigo, et al.
Publicado: (2020)

Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study
por: Horii, Takeshi, et al.
Publicado: (2019)

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data
por: Arai, Taeang, et al.
Publicado: (2021)

Structure-function relationships in the sodium chloride cotransporter
por: Moreno, Erika, et al.
Publicado: (2023)

Special Considerations for Multiple Limb Amputation
por: Pasquina, Paul F., et al.
Publicado: (2014)

Lower Limb Amputation Rates in Germany
por: Walter, Nike, et al.
Publicado: (2022)

Complex multimorbidity and mortality in Japan: a prospective propensity-matched cohort study
por: Kato, Daisuke, et al.
Publicado: (2021)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
por: Bae, Jaehyun, et al.
Publicado: (2022)

Amputation-specific and generic correlates of participation among Veterans with lower limb amputation
por: Erbes, Christopher R., et al.
Publicado: (2022)

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
por: Ansary, Tuba M., et al.
Publicado: (2019)

Risk of contralateral lower limb amputation and death after initial lower limb amputation – a population-based study
por: Huseynova, K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u9om518rcpuc9blb18ka8vb7ip